@article{3130387,
    title = "Rosuvastatin-induced thrombocytopenia",
    author = "Vrettos, I. and Papageorgiou, S. and Economopoulou, C. and Pappa, V. and Tsirigotis, P. and Tountas, N. and Economopoulos, T. and Dervenoulas, J.",
    journal = "Southern Medical Journal",
    year = "2010",
    volume = "103",
    number = "7",
    pages = "676-678",
    issn = "0038-4348, 1541-8243",
    doi = "10.1097/SMJ.0b013e3181e170f5",
    keywords = "C reactive protein;  electrolyte;  hemoglobin;  rosuvastatin;  tumor marker, aged;  anamnesis;  appendectomy;  article;  aspiration;  blood cell count;  blood smear;  bone marrow biopsy;  case report;  cell structure;  drug withdrawal;  dyslipidemia;  echography;  eosinophil;  erythrocyte sedimentation rate;  erythropoiesis;  female;  human;  kidney function test;  leukocyte count;  liver function test;  lymphocyte;  megakaryocyte;  monocyte;  myelopoiesis;  neutrophil;  physical examination;  thorax radiography;  thrombocyte count;  thrombocytopenia;  thyroid function test;  treatment duration;  vitiligo, Aged;  Dyslipidemias;  Female;  Fluorobenzenes;  Humans;  Hydroxymethylglutaryl-CoA Reductase Inhibitors;  Pyrimidines;  Sulfonamides;  Thrombocytopenia",
    abstract = "Rosuvastatin, a statin indicated for patients with primary hypercholesterolemia, mixed dyslipidemia and familial hypercholesterolemia, is well tolerated by most patients. Its most common adverse effects are gastrointestinal derangement, muscle aches and hepatitis. One rare complication of statin treatment is severe thrombocytopenia. The case of a 65-year-old patient who developed severe thrombocytopenia while on rosuvastatin is presented, in addition to a review of the literature. Copyright © 2010 by The Southern Medical Association."
}